Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Accolade Inc (NQ: ACCD )

8.202 +0.512 (+6.66%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,577,377
Open 7.690
Bid (Size) 8.200 (50)
Ask (Size) 8.240 (195)
Prev. Close 7.690
Today's Range 7.595 - 8.240
52wk Range 4.610 - 55.47
Shares Outstanding 67,294,511
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.3% to $1.03 during Wednesday's after-market session. The company's market cap stands at $33.2 million. 
Via Benzinga
NASDAQ: ACCD Investor Alert: Investigation over Potential Wrongdoing at Accolade, Inc.
San Diego, CA -- (SBWIRE) -- 06/16/2022 -- An investigation on behalf of investors in Accolade, Inc. (NASDAQ: ACCD) shares over potential wrongdoing at Accolade, Inc. was announced. 
Via SBWire

Performance

YTD
-69.82%
-69.82%
1 Month
+39.49%
+39.49%
3 Month
-48.19%
-48.19%
6 Month
-68.83%
-68.83%
1 Year
-84.53%
-84.53%

More News

Read More
NASDAQ:ACCD Shareholder Notice: Investigation over Potential Securities Laws Violations by Accolade, Inc.
Via SBWire
Ongoing Investigation Notice: The Schall Law Firm Encourages Investors in Accolade, Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Earnings
Exposures Financial
Ongoing Investigation Reminder: The Schall Law Firm Encourages Investors in Accolade, Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Earnings
Exposures Financial
Why Is Accolade (ACCD) Stock Up Today?
Via InvestorPlace
Why Are Accolade Shares Down Over 40% Today
Via Benzinga
Ongoing Investigation Alert: The Schall Law Firm Encourages Investors in Accolade, Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Earnings
Exposures Financial
Investigation Notice: The Schall Law Firm Encourages Investors in Accolade, Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Topics Earnings
Exposures Financial
Mid-Afternoon Market Update: Nasdaq Gains 100 Points; First Wave BioPharma Shares Plunge
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
66 Biggest Movers From Yesterday
Via Benzinga
Mid-Day Market Update: Dow Drops Over 100 Points; Hilltop Holdings Shares Spike Higher
Via Benzinga
31 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Analyzing Accolade's Short Interest
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2022
Via Benzinga
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Accolade, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
70 Biggest Movers From Friday
Via Benzinga
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Accolade, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
ACCD EQUITY ALERT: Rosen Law Firm Encourages Accolade, Inc. Investors with Losses to Inquire About Securities Class Action Investigation – ACCD
From Rosen Law Firm
Via Business Wire
Mid-Afternoon Market Update: Nasdaq Down 3%; Accolade Shares Slide
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Mid-Day Market Update: Dow Dips 500 Points; GTY Technology Holdings Shares Jump
Via Benzinga
48 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 29, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.